Hello,

Welcome to our flagship newsletter, MarketBeat Daily Ratings.

We'll deliver the latest "Buy" and "Sell" ratings from Wall Street's top-rated analysts directly to your inbox each morning.

But first, we need you to do two quick things:

1. Hit reply, and send a simple "Yes." Just one word. This tells Google (and other emails providers) that you actually want to get our newsletter.

2. After that, this link to confirm your subscription. That will tell us that you received our welcome email and that we should start sending your daily report. 

Confirm your subscription here.

After you have completed these two steps, we would like to gift you a free copy of one of our most popular investing reports: 7 Stocks to Buy and Hold Forever. You can download the report with this link.

Thank you again for subscribing. We look forward to being an important part of your investing journey

Matthew Paulson
Founder and CEO, MarketBeat.

P.S. If you didn’t intend to subscribe, no problem—you can unsubscribe with this link.

(ARReply-161)

Marex Stock Doubles on Record Profits, But Can the Rally Continue?

Reported by Peter Frank. Article Posted: 9/16/2026.

Marex Group (NASDAQ: MRX) has spent the past two years transforming itself from a specialty commodities broker into a much broader financial infrastructure company. That transformation has paid off.

Shares have more than doubled over the past 12 months. The company has reported a string of record profits, pursued aggressive acquisitions and relocated its corporate headquarters—all signs of a business outgrowing its original footprint. Analysts rate the company a Buy. The question for investors is less about whether Marex's business is working and more about whether the stock's run over the past year has already reflected most of that good news.

Marex Shares Surge on Record Growth

Here’s Why Trump Won’t End The Iran War (Ad)

Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up.

One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing.

See the real reason this conflict may never fully end.

Uncover the real reason Trump may never end this war

Marex's stock reached an all-time high of $79.11 per share in early September before pulling back slightly, though shares remain close to their peak. The stock is up about 80% year to date and 109% over the past 12 months.

The recent run-up followed Marex's second-quarter report, released in mid-August, which marked the company's sixth consecutive quarter of record profits since it went public in 2024.

The top-line figures told a clear story. Marex generated $695.8 million in revenue during the second quarter, up 39% from a year earlier. Adjusted profit before tax jumped 56% to $165.9 million.

Adjusted diluted earnings per share (EPS) rose 61% to $1.64, comfortably ahead of Wall Street's estimates. For the first half of 2026, revenue reached $1.388 billion, a 43% increase from a year earlier, while adjusted profit before tax rose 57% to $318.6 million.

Earnings Growth Continues to Accelerate

This pattern has been evident for some time. Full-year 2025 revenue and earnings both grew substantially from the prior year. Revenue came in at $2.02 billion, up 27%, while adjusted profit before tax climbed 30% to $418.1 million, or $3.86 per diluted share, extending several years of compounding growth. Margins have widened alongside that growth, with the company's adjusted profitability metrics improving meaningfully from the prior year.

Acquisitions Expand Marex’s Reach

With a modest 64-cent annual dividend yielding less than 1%, the investment thesis rests on more than a single strong quarter. Management has told analysts that it expects profit growth to remain at the high end of its long-term target range, with acquisitions contributing a meaningful share of that growth.

Since early 2026, Marex has agreed to or completed four separate deals. These transactions expand its reach into UK equity market making, European equity derivatives, European fixed-income market making and clearing operations in Singapore, while adding substantial client balances and deeper access to Chinese markets.

On the infrastructure side, management is building new capabilities in treasury cross-margining, stablecoin collateral and tokenized repo. It also plans to establish a clearing link into prediction markets—bets that global markets will continue shifting toward digital platforms.

The company also completed a corporate move from England and Wales to Bermuda over the summer. That move was paired with a shareholder request for buyback authority, suggesting management sees room to return capital to shareholders.

Analysts Remain Bullish

Wall Street has largely remained bullish through the stock's surge. With a Buy rating from Wall Street, seven analysts rate the stock a Buy and one rates it a Strong Buy, while just one considers it a Hold.

The average 12-month consensus price target is $82 per share, implying roughly 20% upside. The highest price target is $90, while the lowest is $75 per share. Over the past three months, analysts have issued a series of target increases, including one upgrade to Strong Buy in June.

Even so, investors may wonder whether the market has already priced in a substantial amount of optimism.

Risks Rise Along With the Valuation

Skepticism is warranted before buying purely on momentum.

Marex's underlying business carries meaningful operating risk. The company is fundamentally a market maker and clearing house that earns money from trading volume and volatility across commodities, metals, energy and fixed income. A sharp slowdown in those markets could therefore pressure revenue quickly.

The firm also regularly issues principal-at-risk structured notes to retail buyers, a reminder that Marex operates in complex derivatives markets rather than as a simple brokerage.

Four bolt-on acquisitions in roughly a year also raise the usual integration risks associated with an aggressive dealmaking pace, even as management insists its approach remains disciplined.

Marex Must Keep Delivering

For growth-minded investors, Marex still presents a compelling story as a diversifying, increasingly digital-minded financial platform that is compounding earnings faster than many of its peers.

After nearly doubling over the past year, however, the stock is no longer an undiscovered idea. It is a momentum stock that must continue delivering record quarters to justify its current valuation.

Whether Marex belongs in a portfolio ultimately depends on how much confidence an investor has that the company's record growth has room to continue.